Pharma, HealthCare & MedTech
The healthcare market is more than ever driven by health economics and patient empowerment: we know the industry, its specific challenges and we prepare our clients with the right strategy.
MEDICINE IS INNOVATION
The convergence of breakthrough scientific innovation, digital innovation and new business models are reshaping the life sciences space. Consumers’ behavior is evolving, non-traditional healthcare players are disrupting the market. Sustainable healthcare companies should put a greater focus on evidence-based therapies. The reimbursement of technologies becomes increasingly more stringent and the demands on “Innovators” become stricter. Confronted with time-consuming development and licensing processes, ever-changing legal requirements as well as immense cost pressure, healthcare companies nowadays face greater hurdles than in the past.
Multinational healthcare companies rely more and more on acquisitions, licensing and alliances. Digital transformation plays a bigger role in the sector – especially for healthcare providers.
goetzpartners supports healthcare companies in fulfilling the altered conditions and increased regulations. With a unique combination of in-depth corporate finance and management consulting expertise, we are able to work out individual and directly efficient solutions together with our clients.
Healthcare Compass Symposium
goetzpartners regularly organizes the Healthcare Compass Symposium. Each event in the series explores a particular issue in the healthcare sector, bringing together leading experts, innovators, healthcare decision makers, and advisers from both the government and private sectors. At our latest event on May 6, 2022, the future and opportunities of digital health ecosystems have been discussed based on these two guiding questions:
- A new breed of eHealth players is challenging the established providers – what are the strategies to avoid a ‘Kodak moment’?
- Will ‘hybrid healthcare’ fulfil its promises to improve patient care and economics, or mainly add costs to already over-stretched health budgets
We have accompanied numerous healthcare-relevant transactions. With over 200 international sell-side and buy-side transactions totaling in excess of 15 billion euros in the last ten years alone, goetzpartners is one of the most successful mid-market M&A firms. This success is founded on our sector expertise and excellent process management, valued by financial investors and corporate clients alike.